M. Mack

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study

Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease et al. · Arthritis & Rheumatism · 2009 · 595 citations

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

Robert D. Inman, John C. Davis, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2008 · 590 citations

Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.

Margaret B. Rennels, Roger I. Glass, Penelope H. Dennehy et al. · PubMed · 1996 · 308 citations

Picosecond laser pulses

A. J. DeMaria, William H. Glenn, M. J. Brienza et al. · Proceedings of the IEEE · 1969 · 211 citations

Optical Materials, Engineering, Laser Science +20

Golimumab in psoriatic arthritis: One‐year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo‐controlled trial

Arthur Kavanaugh, Désirée van der Heijde, Iain B. McInnes et al. · Arthritis & Rheumatism · 2012 · 206 citations · Full text